Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Koenecke

Showing results (81-90 of 106) with videos related to

Pageof 11
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 7, 2018
Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple MyelomaLaurent Garderet, Simona Iacobelli, Linda Koster, et al.
Journal for Immunotherapy of Cancer|January 10, 2024
Endothelial Activation and Stress Index (EASIX) to predict mortality after allogeneic stem cell transplantation: a prospective studyOlaf Penack, Thomas Luft, Christophe Peczynski, et al.
Frontiers in Immunology|October 13, 2023
Organ complications after CD19 CAR T-cell therapy for large B cell lymphoma: a retrospective study from the EBMT transplant complications and lymphoma working partyOlaf Penack, Christophe Peczynski, Christian Koenecke, et al.
Frontiers in Immunology|December 27, 2023
ECP versus ruxolitinib in steroid-refractory acute GVHD - a retrospective study by the EBMT transplant complications working partyOlaf Penack, Christophe Peczynski, William Boreland, et al.
JHEP Reports : Innovation in Hepatology|December 9, 2025
From model to man: Understanding Tregs' dual role in MASLDJanine Dywicki, Laura Elisa Buitrago-Molina, Anna K Baumann, et al.
Cancers|January 10, 2026
High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European RegistryBertrand Pourroy, Maria D Aumente, Christian Koenecke, et al.
Bone Marrow Transplantation|January 6, 2024
ECP versus ruxolitinib in steroid-refractory chronic GVHD - a retrospective study by the EBMT transplant complications working partyOlaf Penack, Christophe Peczynski, William Boreland, et al.
Annals of Hematology|June 15, 2017
Individual outcome prediction for myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia from MDS after allogeneic hematopoietic cell transplantationMichael Heuser, Razif Gabdoulline, Patrick Löffeld, et al.
Cancers|March 28, 2026
Correction: Pourroy et al. High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry. <i>Cancers</i> 2026, <i>18</i>, 124Bertrand Pourroy, Maria D Aumente, Christian Koenecke, et al.
British Journal of Haematology|March 2, 2019
Impact of primary disease on outcome after allogeneic stem cell transplantation for transformed secondary acute leukaemiaNicolaus Kröger, Diderik-Jan Eikema, Linda Köster, et al.
Pageof 11

Showing results (81-90 of 106) with videos related to

Sort By:
Pageof 11
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 7, 2018
Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple MyelomaLaurent Garderet, Simona Iacobelli, Linda Koster, et al.
Journal for Immunotherapy of Cancer|January 10, 2024
Endothelial Activation and Stress Index (EASIX) to predict mortality after allogeneic stem cell transplantation: a prospective studyOlaf Penack, Thomas Luft, Christophe Peczynski, et al.
Frontiers in Immunology|October 13, 2023
Organ complications after CD19 CAR T-cell therapy for large B cell lymphoma: a retrospective study from the EBMT transplant complications and lymphoma working partyOlaf Penack, Christophe Peczynski, Christian Koenecke, et al.
Frontiers in Immunology|December 27, 2023
ECP versus ruxolitinib in steroid-refractory acute GVHD - a retrospective study by the EBMT transplant complications working partyOlaf Penack, Christophe Peczynski, William Boreland, et al.
JHEP Reports : Innovation in Hepatology|December 9, 2025
From model to man: Understanding Tregs' dual role in MASLDJanine Dywicki, Laura Elisa Buitrago-Molina, Anna K Baumann, et al.
Cancers|January 10, 2026
High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European RegistryBertrand Pourroy, Maria D Aumente, Christian Koenecke, et al.
Bone Marrow Transplantation|January 6, 2024
ECP versus ruxolitinib in steroid-refractory chronic GVHD - a retrospective study by the EBMT transplant complications working partyOlaf Penack, Christophe Peczynski, William Boreland, et al.
Annals of Hematology|June 15, 2017
Individual outcome prediction for myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia from MDS after allogeneic hematopoietic cell transplantationMichael Heuser, Razif Gabdoulline, Patrick Löffeld, et al.
Cancers|March 28, 2026
Correction: Pourroy et al. High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry. <i>Cancers</i> 2026, <i>18</i>, 124Bertrand Pourroy, Maria D Aumente, Christian Koenecke, et al.
British Journal of Haematology|March 2, 2019
Impact of primary disease on outcome after allogeneic stem cell transplantation for transformed secondary acute leukaemiaNicolaus Kröger, Diderik-Jan Eikema, Linda Köster, et al.
Pageof 11